Replies to post #1700 on Dynavax Technologies Corp (DVAX)

[legalizeMJ]

DVAX vs OCRX(pharma stocks)

1)DVAX and OCRX are Pharma stocks with big potentials.
2)DVAX= up
3)DVAX= $5.9 per share.
4)OCRX= ONLY $1.02
5)OCRX is UP. Here's Why

1)
A positive update to the STOP H.E. trial: ? http://ir.ocerainc.com/releasedetail.cfm?ReleaseID=1016492?

2)
You can also listen to its 3/8/17 Conference Call here:

http://wsw.com/webcast/cowen38/ocrx/

Basically their drug(OCR-002) is far better than what is currently used to treat HE which is Refaximin. It had about 1 billion in sales last year (Refaximin). OCR-002 doesn't have awful side effects like Refaximin.

Essentially their new drug should replace Refaximin and get a large portion of those 1 billion in sales.

[legalizeMJ]

DVAX vs CATB(Pharma stocks)

1)CATB= DMD stock.

2)CATB= UP BIG because CATB is a Hot DMD stock.
3)
Listened to the CATB presentation. Promising outlook and slides at Cowen and Company’s 37th Annual Health Care Conference.

http://ir.catabasis.com/phoenix.zhtml?c=251269&p=irol-EventDetails&EventId=5250554
4)
CATB= UP BIG because CATB is a Hot DMD stock.